REG - IXICO plc - Result of AGM

IXICOAnnouncement

18/01/2019 10:10

RNS Number : 4898N
IXICO plc
18 January 2019
 


18 January 2019
 
IXICO plc
("IXICO" or the "Company")
 
Results of AGM
 
 
IXICO plc (AIM: IXI), the digital technologies company serving neuroscience, announces that all resolutions put to its Annual General Meeting held earlier today were duly passed.
 
For further information please contact:
 



IXICO plc
Giulio Cerroni, Chief Executive Officer


 
Tel: +44 20 3763 7499














Shore Capital (Nomad and Broker)
Edward Mansfield / Anita Ghanekar / Daniel Bush


Tel: +44 20 7408 4090














FTI Consulting Limited (Investor Relations)
Simon Conway


Tel: +44 20 3727 1000



 
About IXICO
IXICO is dedicated to delivering insights in neuroscience. Our mission is to transform the progression of our biopharmaceutical clients' neurological therapeutic pipelines through the application of novel medical imaging and mobile health digital technologies.
 
IXICO's data analytics services are used by the global biopharmaceutical industry to interpret data from brain scans and digital biosensors to enable better trial design, site qualification, patient selection and clinical outcomes. We provide technology-enabled services across all phases of clinical evaluation. Our integrated digital platform provides a scalable and secure infrastructure for the capture and analysis of regulatory compliant clinical data to enable clients to make rapid, better informed decisions. IXICO is also collaborating with partners to develop new analytical techniques and companion digital health products targeted at improving patient outcomes.
 
More information is available on www.IXICO.com




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGCKFDDFBKKDDD